<DOC>
	<DOCNO>NCT02302573</DOCNO>
	<brief_summary>Abnormally invasive placenta ( AIP ) define abnormal placental attachment part entire chorionic plate penetration chorionic villus myometrium absence decidua basalis . This anomaly associate significant maternal morbidity mortality may result severe haemorrhage post-partum . It demonstrate prenatal diagnosis AIP essential reduce maternal morbidity . In recent study Chantraine F. et al . prenatal diagnosis AIP lead good outcome , due few emergency operation less mass transfusion . Currently , diagnosis AIP base combination conventional B-mode ultrasound MRI . However , prenatal diagnosis AIP remain challenging recent report demonstrate achieved third case . Contrast enhance ultrasound ( CEUS ) non-invasive technique base detection ultrasound ( US ) gas-filled microbubbles use perfusion tracer . Intravascular rheological property bubble similar red blood cell remain entirely within intravascular space . Previous study demonstrate microbubbles transfer fetal circulation . CEUS use year many US image application ( e.g . liver , kidneys breast ) . In obstetrics , despite yet approve clinical use , CEUS offer opportunity analyze anatomical placental landmark , improve contrast placenta myometrium . In addition , quantification parameter relate contrast enhancement propose objective indicator estimate blood perfusion rate placental intervillous space . The main objective study provide pre-clinical evaluation CEUS diagnosis AIP try determine AIP characterise difference intervillous blood rheological property . Conventional CEUS parameter : rise time , peak enhancement , wash-in rate , mean transit time wash-in area curve . As study pre-clinical evaluation , sample size calculation remain subjective imprecise . For reason , sample size 100 pregnant woman include prospective study decide . The potential impact study propose reliable tool improve sensibility specificity compare combination US/MRI therefore reduce maternal worldwide burden AIP .</brief_summary>
	<brief_title>Placenta Accreta : Contrast-enhanced Ultrasound Analysis High Risk Population</brief_title>
	<detailed_description />
	<mesh_term>Placenta Accreta</mesh_term>
	<criteria>Pregnant patient follow two condition : Scar uterus ( previous cesarean ) placenta previa partly wholly uterine scar Placenta praevia patient age 35 year Term &gt; 34 week amenorrhea More 18 year old Inform consent form sign affiliated medical insurrance Inability understand information Contraindications contrast medium Sonovue : Hypersensitivity hexafluorinated sulphur component Sonovue Recent acute coronary syndrome ( within 6 month intervention ) Unstable ischemic heart disease ( myocardial infarction form evolve , typical angina rest previous month ) Significant worsen cardiac symptom pre anaesthesia consultation intervention Recent intervention ( le 6 month ) coronary artery factor suggest clinical instability ( change ECG , change clinical biological parameter ) Acute heart failure heart failure stage III IV Severe arrhythmia Rightleft shunt Acute endocarditis Valve prothesis Severe pulmonary hypertension ( pulmonary artery pressure &gt; 90mmHg ) Systemic hypertension uncontrolled Respiratory distress syndrome</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>placenta accreta</keyword>
	<keyword>contrast-enhanced unltrasound</keyword>
	<keyword>pregnancy</keyword>
	<keyword>MRI</keyword>
	<keyword>sonovue</keyword>
</DOC>